Wednesday, February 13, 2013

• 3 Stocks Pushing The Drugs Industry Higherat TheStreet (Wed, Feb 13)
• Gilead Reaches New 52-Week High (GILD)at TheStreet (Wed, Feb 13)

Tuesday, February 12, 2013

• Bayer Seeks Riociguat ApprovalZacks (Tue, Feb 12)

Monday, February 11, 2013

• Fisking Ray Dirks On Medgenics And Shaming Seeking Alphaat TheStreet (Mon, Feb 11)
• Gilead Closes YM Biosciences BuyoutZacks (Mon, Feb 11)
• Gilead Sciences to Present at Two Upcoming Investor ConferencesBusiness Wire (Mon, Feb 11)
• Disappointing Fourth Quarter - Reason to Sell?at Motley Fool (Mon, Feb 11)
• HIV/AIDS and Gilead Sciencesat Motley Fool (Mon, Feb 11)
• Six Things to Watch at Biotech CEO Conferenceat Minyanville (Mon, Feb 11)

Saturday, February 9, 2013

• Has Gilead Sciences Become the Perfect Stock?at Motley Fool (Sat, Feb 9)

Friday, February 8, 2013

• Gilead Sciences Inc (GILD): Today's Featured Drugs Winnerat TheStreet (Fri, Feb 8)
• Gilead Sciences completes acquisition of YM BioSciencesCNW Group (Fri, Feb 8)
• Gilead Sciences Completes Acquisition of YM BioSciencesBusiness Wire (Fri, Feb 8)
• Time to Buy These Biotechnology Companies?at Motley Fool (Fri, Feb 8)
• This News Makes Gilead the Top Healthcare Pickat Motley Fool (Fri, Feb 8)
• ShinesRooms Research on Gilead and Hemispherx: Biotech Companies Seek New PasturesAccesswire (Fri, Feb 8)

Thursday, February 7, 2013

• Best of the Biotech Industryat Motley Fool (Thu, Feb 7)
• [video] The Next Big Thing In Biotech: BIO CEO Conferenceat TheStreet (Thu, Feb 7)
• Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD)at TheStreet (Thu, Feb 7)
• Ariad commits to independence despite acquisition speculationat bizjournals.com (Thu, Feb 7)

Wednesday, February 6, 2013

• [video] Are You Diversified? Cramer's Call!at CNBC (Wed, Feb 6)
• Walgreen Sales are Up and 2 stocks At 52-Week Highsat Wall St. Cheat Sheet (Wed, Feb 6)
• U.S. Food and Drug Administration Approved 30% More Drugs in 2012Marketwired (Wed, Feb 6)

Tuesday, February 5, 2013

• Gilead Sciences Earnings Call Nuggets: Genotype 3 Market and Short Duration Studiesat Wall St. Cheat Sheet (Tue, Feb 5)
• Gilead CEO John Martin wins 2012 bonus of $3.4 millionat bizjournals.com (Tue, Feb 5)

Add GILD News to My Yahoo!